NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $285,071 | -24.3% | 14,832 | +0.0% | 0.00% | – |
| Q2 2023 | $376,661 | -29.8% | 14,829 | -0.1% | 0.00% | – |
| Q1 2023 | $536,645 | +102.5% | 14,847 | +121.9% | 0.00% | – |
| Q4 2022 | $264,964 | -15.1% | 6,691 | 0.0% | 0.00% | – |
| Q3 2022 | $312,000 | +6.5% | 6,691 | +0.2% | 0.00% | – |
| Q2 2022 | $293,000 | -39.3% | 6,680 | -0.1% | 0.00% | – |
| Q1 2022 | $483,000 | -10.9% | 6,684 | +0.0% | 0.00% | – |
| Q4 2021 | $542,000 | +40.1% | 6,682 | +101.2% | 0.00% | – |
| Q3 2021 | $387,000 | -99.5% | 3,321 | -99.7% | 0.00% | -100.0% |
| Q3 2018 | $70,778,000 | -53.0% | 1,241,720 | -34.1% | 0.04% | -55.8% |
| Q2 2018 | $150,562,000 | -14.4% | 1,885,555 | -7.1% | 0.09% | -17.3% |
| Q1 2018 | $175,838,000 | +54.1% | 2,028,820 | +22.8% | 0.10% | +48.6% |
| Q4 2017 | $114,092,000 | +0.5% | 1,652,556 | +32.3% | 0.07% | -4.1% |
| Q3 2017 | $113,542,000 | +7.3% | 1,249,367 | -12.1% | 0.07% | +1.4% |
| Q2 2017 | $105,837,000 | – | 1,421,967 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
| Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
| Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
| Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
| ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
| FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
| PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
| FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
| Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
| K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |